EPA and DHA

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	1

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01826422 (ClinicalTrials.gov)	March 2013	4/4/2013	Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients	Effect of Eicosapentaenoic Fatty Acid (EPA) andDocosahexaenoic Fatty Acids (DHA) Supplementation on ...	Muscular Dystrophy, Duchenne	Dietary Supplement: EPA and DHA;Dietary Supplement: Placebo Comparator	Coordinación de Investigación en Salud, Mexico	Instituto Nacional de Rehabilitacion	Completed	6 Years	18 Years	Male	40	N/A	Mexico

First Previous1Next Last